Brian M. Larkin - 03 Oct 2023 Form 4 Insider Report for DYNATRONICS CORP (DYNT)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
05 Oct 2023, 20:05:51 UTC
Prior SEC filing
07 Jul 2023
Next SEC filing
04 Jan 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Brian M. Larkin

Key filing fact

Brian M. Larkin filed Form 4 for DYNATRONICS CORP (DYNT) on 05 Oct 2023.

Key facts

  • This page summarizes Brian M. Larkin's Form 4 filing for DYNATRONICS CORP (DYNT).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 05 Oct 2023, 20:05.

Change

  • Previous filing in this sequence was filed on 07 Jul 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DYNT transaction

Common

Other

Transaction value
Shares
+5,332
Change %
+9.4%
Price
Shares after
62,257
Date
03 Oct 2023
Ownership
Direct
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Payment of quarterly dividend on 8% Preferred Stock in shares of common stock valued at 90% of 10-day average closing bid price.

Footnote F2

Shares Owned: The reported value following this transaction is reflective of an administrative correction to the value reported on July 7, 2023.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .